secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K/A
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001801170-26-000071
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health publishes supplemental shareholder Q&A; no new financial data disclosed
--------------------------------------------------------------------------------

- Filed 8-K/A on March 6, 2026 furnishing a supplemental Q&A document related to Q4 2025 earnings.
- Document contains selected responses to shareholder questions but includes no specific financial or operational metrics.
- CEO Andrew Toy reaffirms commitment to shareholder transparency in the accompanying letter.
- Q&A is also available on the investor relations page of Clover Health's website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000071/0001801170-26-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000071/clov-20260306.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer